Sort
39,280 grants matching “leukemia”
Novel synthetic receptors with improved antigen specificity and specificity for cancer therapy
$435,730Stanley R Riddell · Fred Hutchinson Cancer Center · R01 · FY2025 · CA
Novel synthetic receptors with improved antigen specificity and specificity for cancer therapy
$435,730Stanley R Riddell · Fred Hutchinson Cancer Center · R01 · FY2023 · CA
Statistical Methods with Applications to Toxicology and Microarray data
$435,714Shyamal Peddada · National Institute Of Environmental Health Sciences · ZIA · FY2010 · ES
Coordinate Regulation of p53 and c-MYC in an HTLV-1 Model of Carcinogenesis
$435,686Robert L. Harrod · Southern Methodist University · R15 · FY2012 · CA
A novel role of the viral protein HBZ in mediating HTLV-1 infection.
$435,664Isabelle Michele Lemasson · East Carolina University · R15 · FY2017 · AI
Precision Targeting of Myeloid Src-family Kinases in Acute Myelogenous Leukemia
$435,632Thomas Edward Smithgall · University Of Pittsburgh At Pittsburgh · R01 · FY2020 · CA
Precision Targeting of Myeloid Src-family Kinases in Acute Myelogenous Leukemia
$435,632Thomas Edward Smithgall · University Of Pittsburgh At Pittsburgh · R01 · FY2019 · CA
Precision Targeting of Myeloid Src-family Kinases in Acute Myelogenous Leukemia
$435,632Thomas Edward Smithgall · University Of Pittsburgh At Pittsburgh · R01 · FY2021 · CA
Preclinical Diagnostic Imaging of Amyloid
$435,627Jonathan S Wall · University Of Tennessee Knoxville · R01 · FY2012 · DK
Phase I/II clinical trial of HDAC inhibition for GVHD prevention in children, adolescents, and young adults
$435,611Sung Won Choi · University Of Michigan At Ann Arbor · R01 · FY2022 · CA
Phase I/II clinical trial of HDAC inhibition for GVHD prevention in children, adolescents, and young adults
$435,611Sung Won Choi · University Of Michigan At Ann Arbor · R01 · FY2023 · CA
Biology and Prognostic implications of Flt3 mutations in AML
$435,609Soheil Meshinchi · Fred Hutchinson Cancer Research Center · R01 · FY2009 · CA
Shwachman-Diamond Syndrome: Molecular Pathogenesis
$435,600Akiko Shimamura · Fred Hutchinson Cancer Research Center · R01 · FY2012 · HL
Elucidating the Functional and Mechanistic Roles of LINE-1 Retrotransposons in Myeloid Leukemia
$435,519Jian Xu · Ut Southwestern Medical Center · R01 · FY2022 · CA
Epigenetic drivers of cancer progression
$435,427Andrew P Feinberg · Johns Hopkins University · R01 · FY2023 · CA
Mobilizing Adult Neural Stem Cells and Disease Models
$435,353Paul H Patterson · California Institute Of Technology · R01 · FY2010 · NS
EASTERN COOPERATIVE ONCOLOGY GROUP
$435,349Vanderbilt University · U10 · FY2002 · CA
Mechanisms of targeting cellular self-renewal in glioblastoma
$435,248Hatem Sabaawy · University Of Colorado Denver · R01 · FY2022 · CA
Interplay Between Cancer and Immune Cells on Targeted Therapy
$435,170Peter Poon-Hang Lee · Stanford University · R01 · FY2008 · CA
SOUTHWEST ONCOLOGY GROUP/UNIVERSITY OF CALIFORNIA, DAVIS
$435,092University Of California Davis · U10 · FY2003 · CA
Retroviral Coded Functions
$435,066Fred Hutchinson Cancer Research Center · R01 · FY2004 · CA
Regulation of Chromatin Structure Dynamics in Hematopoietic and Leukemic Stem Cel
$435,055Camilla Forsberg · University Of California Santa Cruz · R01 · FY2017 · HL
Analysis of neuropoietic cytokines and their receptors in diabetic neuropathy
$435,003Lisa Renee Banner · California State University Northridge · R15 · FY2012 · NS
Molecular biology of myeloid differentiation
$435,000Daniel G Tenen · Beth Israel Deaconess Medical Center · R01 · FY2012 · HL
Cancer and Leukemia Group B - The Ohio State University
$434,962Clara D Bloomfield · Ohio State University · U10 · FY2007 · CA